In this issue we bring together a truly multidisciplinary group of experts to discuss the challenges and advances that have been made in diagnosis and treatment of patients with potentially curable disease. We are honred to have Prof. Heather Wakelee from Stanford Center institue as the Guest Editor for this issue. Together with authors from North America, Europe and Asia, the topics are hot and extensive, covering five different treatment modalities in addition to the basic science underlying therapeutic decisions. It is expected that readers would come away with a more thorough understanding of the state of the art and future directions in the care of patients with early stage NSCLC.
